Back to search
FDAFDA · Food and drugs·Recall number Z-1617-2024

Biomet OrthoPak Non-invasive Bone Growth Stimulator System-Indicated for the treatment of an established nonunion acquired secondary to trauma, excluding vertebrae and all flat bones. Part Number: 1067718

Published May 1, 2024 · Recall initiated: March 22, 2024

Summary

FDA records medical device Class II recall Z-1617-2024, published May 1, 2024 and initiated March 22, 2024. Recalling firm: EBI, LLC; Status: Ongoing; Reported quantity: 1412 units ( 2 leads per assembly); Lot: UD-DI: 00812301020232 All devices distributed since May 1, 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Damage to the lead wire sheath (black cable) component and causing exposure of the wires, potentially lead to no therapeutic treatment signal being delivered to the electrodes, and result in delay of treatment

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
EBI, LLC
Distributor
US Nationwide distribution.
Lot
UD-DI: 00812301020232 All devices distributed since May 1, 2023
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Biomet OrthoPak Non-invasive Bone Growth Stimulator System-Indicated for the treatment of an established nonunion acquired secondary to trauma, excluding vertebrae and all flat bones. Part Number: 1067718 recalled?

Yes. FDA published recall Z-1617-2024 on May 1, 2024. Reported hazard: Damage to the lead wire sheath (black cable) component and causing exposure of the wires, potentially lead to no therapeutic treatment signal being delivered to the electrodes, and result in delay of treatment

What should I do if I have this product?

Voluntary: Firm initiated · Letter